About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 691 record(s)
Req # A-2023-000846
All communications between Health Canada personnel and "Régie de l'assurance maladie du Québec" (RAMQ) personnel that deal with one or more of the following topics: controlled distribution of drugs; notices of compliance with conditions, section 80.2 of Quebec’s Act respecting prescription drug insurance, Compilation of Québec Laws and Regulations (CQLR) c A-29.01; or the RevAid program. For the period January 1, 2021 to September 18, 2023.Organization: Health Canada
October 2023
Req # A-2023-000861
All electronic communications within the Public Health Agency of Canada with respect to the Member of Parliament (MP) Michelle Rempel Garner's Substack article entitled "The Public Health Agency of Canada has a trust deficit, and it could be deadly."Organization: Health Canada
October 2023
Req # A-2023-000870
All documents related thereto in files under the control or the authority of the Health Canada including without limitation in connection with: Corporation: Clinique de Perfusion de Laval Inc. (NEQ: 1176315233). 200-3030 Le Carrefour Boulevard, Laval (Québec) H7T 2P5.Organization: Health Canada
October 2023
Req # A-2023-000871
Information related to the status of the following companies' files with your organization. Company: Gestion Fondateur 3.0 inc. (NEQ: 1175727644) 1470 Graham-Bell Street, Boucherville, QC J4B 6H5, Canada. Company: Gestion immobilière CNC inc. (NEQ: 1172502990) 1470 Graham-Bell Street, Boucherville, QC J4B 6H5, Canada. Company: Mécanique CNC (2002) inc. (NEQ: 1161024147) 1470 Graham-Bell Street, Boucherville, QC J4B 6H5, Canada.Organization: Health Canada
October 2023
Req # A-2023-000894
Number of medical malpractice deaths for the past 6 years, From October 3 2017 to October 3 2023.Organization: Health Canada
October 2023
Req # A-2023-00032
Report R22D0004 concerning a collision between a VIA Rail train and a vehicle that occurred on January 19, 2022, at a crossing at l'Île Perrot, QuebecOrganization: Transportation Safety Board of Canada
October 2023
Req # A-2023-00036
Please provide the staffing document at the Canadian Digital Service (CDS) dated Jun 1, 2021. Reference Number:50675494Organization: Transportation Safety Board of Canada
October 2023
Req # A-2023-00040
I am working on a project and documentary related to the Wapiti Flight 402 plane crash that occurred on October 19, 1984, South of Lesser Slave Lake, Alberta, with aircraft registration C-GXUC. I understand there may be limitations under the Canadian Transportation Accident Investigation and Safety Board Act, but I kindly request any information that can be shared within the confines of applicable laws and regulations to help in our projectOrganization: Transportation Safety Board of Canada
October 2023
Req # A-2023-00041
ITEM#: 185240 TITLE: Champion 7EC - Aircraft accident - Meta Lake, 37 miles northwest of Nakina, Ontario 2 October 1964 REFERENCE NUMBER: RG12-A-1, vol 1583, file 5002-2388Organization: Transportation Safety Board of Canada
October 2023
Req # A-2023-000570
With respect to the New Drug Submission for ABSORICA LD, portions of the New Drug Submission that relate to Sun Pharmaceuticals Industries Limited’s ownership, agreement, or contractual rights to the data in the Phase III study referenced in section “14.1 Clinical Trials by Indication".Organization: Health Canada
September 2023